The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 165-171 , January 2003

Nuclear factor κB mediates a procoagulant response in monocytes during extracorporeal circulation

Received 24 September 2001 ,Revised 29 January 2002 ,Accepted 12 February 2002.

References 

  1. Kappelmayer J, Bernabei A, Edmunds LH, Edgington TS, Colman RW. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res. 1993;72:1075–1081
  2. Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LH. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation. 1996;93:2014–2018
  3. Barstad RM, Ovrum E, Ringdal MA, Oystese R, Hamers MJ, Veiby OP, et al.  Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit. Br J Haematol. 1996;94:517–525
  4. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991;66:67–79
  5. Gando S, Kameue T, Nanzaki S, Hayakawa T, Nakanishi Y. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med. 1997;25:1820–1826
  6. Boyle EM, Verrier ED, Spiess BD. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg. 1996;62:1549–1557
  7. Pohlman TH, Harlan JM. Adaptive responses of the endothelium to stress. J Surg Res. 2000;89:85–119
  8. Mackman N. Regulation of the tissue factor gene. Thromb Haemost. 1997;78:747–754
  9. Santucci RA, Erlich J, Labriola J, Wilson M, Kao KJ, Kickler TS, et al.  Measurement of tissue factor activity in whole blood. Thromb Haemost. 2000;83:445–454
  10. Larsson R, Elgue G, Larsson A, Ekdahl KN, Nilsson UR, Nilsson B. Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface. Immunopharmacology. 1997;38:119–127
  11. Rinder CS, Rinder HM, Smith BR, Fitch JC, Smith MJ, Tracey JB, et al.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 1995;96:1564–1572
  12. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8:397–403
  13. Parratt R, Hunt BJ. Direct activation of factor X by monocytes occurs during cardiopulmonary bypass. Br J Haematol. 1998;101:40–46
  14. Kozek-Langenecker SA, Wanzel O, Berger R, Kettner SC, Coraim F. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1. Anesth Analg. 1998;87:985–988
  15. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, et al.  Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation. 1997;96:3534–3541
  16. Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg. 1997;113:576–584
  17. Plotz FB, van Oeveren W, Bartlett RH, Wildevuur CR. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg. 1993;105:823–832
  18. Wetsel RA. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr Opin Immunol. 1995;7:48–53
  19. Zwirner J, Fayyazi A, Gotze O. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol. 1999;36:877–884
  20. Hsu MH, Wang M, Browning DD, Mukaida N, Ye RD. NF-κB activation is required for C5a-induced interleukin-8 gene expression in mononuclear cells. Blood. 1999;93:3241–3249
  21. Sitrin RG, Kaltreider HB, Ansfield MJ, Webster RO. Procoagulant activity of rabbit alveolar macrophages. Am Rev Respir Dis. 1983;128:282–287
  22. Ikeda K, Nagasawa K, Horiuchi T, Tsuru T, Nishizaka H, Niho Y. C5a induces tissue factor activity on endothelial cells. Thromb Haemost. 1997;77:394–398
  23. Engstad CS, Lia K, Rekdal O, Olsen JO, Osterud B. A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol. 1995;58:575–581
  24. Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology. 1991;75:388–393
  25. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, et al.  Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994;153:3245–3255
  26. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, et al.  Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 1995;9:1586–1597
  27. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 1994;78:773–785
  28. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 1995;2:493–506
  29. Palombella VJ, Conner EM, Fuseler JW, Destree A, Davis JM, Laroux FS, et al.  Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A. 1998;95:15671–15676
  30. Adams J, Palombella VJ, Elliott PJ. Proteasome inhibition: a new strategy in cancer treatment. Invest New Drugs. 2000;18:109–121
  31. Martinez-Martinez S, Gomez del Arco P, Armesilla AL, Aramburu J, Luo C, Rao A, et al.  Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells. Mol Cell Biol. 1997;17:6437–6447
  32. Naldini A, Sower L, Bocci V, Meyers B, Carney DH. Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation. J Cell Physiol. 1998;177:76–84
  33. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 1994;144:975–985
  34. Coughlin SR. How the protease thrombin talks to cells. Proc Natl Acad Sci U S A. 1999;96:11023–11027
  35. Ryu J, Pyo H, Jou I, Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-κB. J Biol Chem. 2000;275:29955–29959
  36. De Candia E, De Cristofaro R, Landolfi R. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin. Circulation. 1999;99:3308–3314

☆ Address for reprints: Timothy H. Pohlman, MD, Harborview Medical Center, 325 9th Ave, Box 359796, Seattle, WA 98104 (E-mail: tpohlman@u.washington.edu).

☆☆ 0022-5223/2003 $30.00+0

PII: S0022-5223(02)73346-1

doi: 10.1067/mtc.2003.99

The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 165-171 , January 2003

Article Tools

* Image Usage & Resolution